Real-time enrollment status for this non-small cell lung cancer clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 3:07 AM UTC
| NCT Number | NCT07538804 |
| Recruiting Status | Recruiting |
| Condition | Non-Small Cell Lung Cancer |
| Phase | PHASE1 |
| Target Enrollment | 294 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Avistone Biotechnology Co., Ltd. |
| Last Updated on CT.gov | July 6, 2026 (Jul 6, 2026) |
As of September 2, 2026: Clinical trial NCT07538804 is currently recruiting participants. This phase1 study for non-small cell lung cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by Avistone Biotechnology Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07538804 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07538804 was last updated Jul 6, 2026 (July 6, 2026). HelloStudys verifies this status automatically.